Scaling up cell and gene therapy processes requires more than just technical expertise; it demands early planning, smart design, and a deep understanding of regulatory expectations. This article explores key considerations for moving from lab-scale development to commercial manufacturing, highlighting strategies that reduce costs, accelerate timelines, and ensure product quality. From selecting the right materials to building robust validation frameworks, it offers insights that help developers avoid common pitfalls and prepare for regulatory success.
Please check the highlighted fields and try again.
Please enter your first and last name.
Please enter the name of the company or institution you work at.
Please enter your mailing address.
By submitting this form, you consent to Cell & Gene Therapy Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.